Arthneeti

Oxygenta Pharmaceutical Share Price & Earnings Call Analysis

₹47.05+0.11% today
Market cap
₹174 Cr
Price to sales
1.29
Debt to equity
0.00
52W high / low
₹67.9 / ₹44.6
Sales growth (5Y)
16.77%
EBITDA margin
-5.92%
Net profit margin
-15.56%
Promoter holding
56.53%
Sales (last year)
₹135 Cr

Potential multibaggers · Q2 FY27

This quarter's potential multibaggers
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Oxygenta Pharma rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Financials of Oxygenta Pharma

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Oxygenta Pharma

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +8.196.8613.089.1510.5512.6214.0133.2149.4715.1314.3033.9349.61
Expenses +10.4410.5015.0611.6312.1714.4016.1837.5751.1521.9618.8738.0149.49
Operating Profit-2.25-3.64-1.98-2.48-1.62-1.78-2.17-4.36-1.68-6.83-4.57-4.080.12
OPM %-27.47%-53.06%-15.14%-27.10%-15.36%-14.10%-15.49%-13.13%-3.40%-45.14%-31.96%-12.02%0.24%
Other Income +-0.05-0.13-0.03-0.020.260.020.750.49-0.220.16-0.060.000.17
Interest0.940.290.340.360.590.410.690.392.130.630.951.391.81
Depreciation0.850.500.830.690.640.650.660.71-0.230.850.860.86-0.24
Profit before tax-4.09-4.56-3.18-3.55-2.59-2.82-2.77-4.97-3.80-8.15-6.44-6.33-1.28
Tax %4.89%0.00%-0.63%6.48%-409.27%-51.42%2.89%-20.72%-43.42%-25.03%-23.45%-23.38%32.81%
Net Profit +-4.29-4.56-3.16-3.788.02-1.36-2.85-3.93-2.15-6.11-4.93-4.84-1.70
EPS in Rs-3.02-1.36-0.94-1.132.40-0.38-0.80-1.06-0.58-1.65-1.33-1.31-0.46

Financials of Oxygenta Pharma

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +612813211452613140109113
Expenses +10161317232248593849119128
Operating Profit-4-4-5-4-2-841-7-10-10-15
OPM %-67%-34%-59%-31%-10%-57%7%2%-23%-24%-9%-14%
Other Income +00110421-1010
Interest011111211225
Depreciation311111122312
Profit before tax-7-6-6-4-3-63-0-11-14-12-22
Tax %-11%0%2%1%-7%-3%7%24%2%-75%-16%-21%
Net Profit +-6-6-6-5-3-63-1-12-3-10-18
EPS in Rs-5.99-5.39-5.70-4.44-3.19-5.682.87-0.43-8.15-1.04-2.62-4.75
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Financials of Oxygenta Pharma

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital101010101010101414333737
Reserves-26-32-38-42-45-51-48-49-60-54-62-80
Borrowings +1517191922274852685762110
Other Liabilities +192427303433241432264653
Total Liabilities1820191721193431546383120
Fixed Assets +121312121211162028294048
CWIP000000100000
Investments000000000000
Other Assets +676597171126344472
Total Assets1820191721193431546383120

Financials of Oxygenta Pharma

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-4111-8-3-2-2-2-133-28
Cash from Investing Activity +1-2-1-0-1-0-7-5-10-4-11-14
Cash from Financing Activity +310-183961117943
Net Cash Flow0-00-0000-0-0-000
Free Cash Flow-7-1-01-8-3-8-7-11-17-9-41
CFO/OP104%-20%-13%-33%396%35%-37%-106%23%135%-28%182%

Financials of Oxygenta Pharma

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days384439149111110120681732
Inventory Days8441122571211001215617814978105
Days Payable1,80066759939620319013750362249113174
Cash Conversion Cycle-1,678-582-439-325-73-79-516-64-32-18-37
Working Capital Days-616-454-512-438-164-275-148-94-89-184-119
ROCE %-1%-47%-42%-25%-33%